Johan F. Vansteenkiste
约翰·范斯滕基斯特
MD, PhD
Professor of Pneumology; Head, Respiratory Oncology Unit肺病学教授；呼吸肿瘤科主任
👥Biography 个人简介
Europe's leading expert in early-stage NSCLC and adjuvant targeted therapy. Key investigator in the ADAURA trial establishing adjuvant osimertinib for resected EGFR-mutant NSCLC, and leading contributor to European perioperative NSCLC treatment paradigms.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
ADAURA Trial - Adjuvant Osimertinib
Served as key European investigator in ADAURA, demonstrating osimertinib's dramatic disease-free survival benefit as adjuvant therapy in resected EGFR-mutant NSCLC, transforming post-surgical management.
Early-Stage NSCLC Management
Contributed seminal data on multidisciplinary management of early-stage NSCLC, integrating molecular profiling with surgical and adjuvant treatment decisions across European cancer centers.
Representative Works 代表性著作
Osimertinib as Adjuvant Therapy in Resected EGFR-Mutated NSCLC (ADAURA)
New England Journal of Medicine (2020)
Practice-changing ADAURA trial showing 83% reduction in disease recurrence or death with adjuvant osimertinib in stage IB-IIIA EGFR-mutant NSCLC.
Staging and Management of Early-Stage NSCLC: ESMO Clinical Practice Guidelines
Annals of Oncology (2021)
Comprehensive ESMO guidelines for early-stage NSCLC management incorporating EGFR mutation testing and adjuvant targeted therapy recommendations.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 约翰·范斯滕基斯特 的研究动态
Follow Johan F. Vansteenkiste's research updates
留下邮箱，当我们发布与 Johan F. Vansteenkiste（KU Leuven / University Hospitals Leuven）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment